Clinical Trials Browser

Hodgkin Disease × Amplified Fragment Length Polymorphism Analysis × 90 days × Clear all

NCT01476410 2026-05-22

Brentuximab Vedotin and Combination Chemotherapy in Treating Older Patients With Previously Untreated Stage II-IV Hodgkin Lymphoma

Phase 2 Completed

49 enrolled 25 charts

Hodgkin Disease